Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample

Psychological Medicine

Volumn 38, Issue 9, 2008, Pages 1267-1276

  Barkus, E ^a   Lewis, S ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cannabis; Psychosis proneness; Schizotypy

Indexed keywords

ALCOHOL; CANNABIS; RECREATIONAL DRUG;

ARTICLE; CANNABIS EXPERIENCES QUESTIONNAIRE; CIGARETTE SMOKING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMETRY; PSYCHOSIS; QUESTIONNAIRE; SCHIZOTYPAL PERSONALITY QUESTIONNAIRE; SCHIZOTYPY;

ADULT; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; PSYCHOMETRICS; PSYCHOSES, SUBSTANCE-INDUCED; QUESTIONNAIRES; SCHIZOTYPAL PERSONALITY DISORDER; SELF DISCLOSURE; STREET DRUGS; STUDENTS;

EID: 48749124677     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291707002619     Document Type: Article

References (30)

1. Appels MC, Sitskoorn MM, Vollema MG, Kahn RS (2004). Elevated levels of schizotypal features in parents of patients with a family history of schizophrenia spectrum disorders. Schizophrenia Bulletin 30, 781-790.
2. Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P (2005). Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry 187, 510-515.
3. Baigent M, Holme G, Hafner RJ (1995). Self reports of the interaction between substance abuse and schizophrenia. Australian and New Zealand Journal of Psychiatry 29, 69-74.
4. Barkus EJ, Stirling J, Hopkins RS, Lewis S (2006). Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39, 175-178.
5. Barkus EJ, Stirling J, Hopkins RS, McKie S, Lewis S (2007). Cognitive and neural processes involved in non-clinical auditory hallucinations. British Journal of Psychiatry 191 (Suppl. 51), s76-s81.
6. Degenhardt L, Hall W (2006). Is cannabis use a contributory cause of psychosis? Canadian Journal of Psychiatry 51, 556-565.
7. Diwadkar VA, Montrose DM, Dworakowski D, Sweeney JA, Keshavan MS (2006). Genetically predisposed offspring with schizotypal features: an ultra high-risk group for schizophrenia? Progress in Neuropsychopharmacology and Biological Psychiatry 30, 230-238.
8. D'Souza DC, Abi-Saab WM, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper TB, Krystal JH (2005). Delta-9- tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biological Psychiatry 57, 594-608.
9. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29, 1558-1572.
10. Dumas P, Saoud M, Bouafia S, Gutknecht C, Ecochard R, Dalery J, Rochet T, d'Amato T (2002). Cannabis use correlates with schizotypal personality traits in healthy students. Psychiatry Research 109, 27-35.
11. Earleywine M (2006). Schizotypy, marijuana, and differential item functioning. Human Psychopharmacology 21, 455-461.
12. Fanous AH, Neale MC, Gardner CO, Webb BT, Straub RE, O'Neill FA, Walsh D, Riley BP, Kendler KS (2007). Significant correlation in linkage signals from genome-wide scans of schizophrenia and schizotypy. Molecular Psychiatry 12, 958-965.
13. Fendrich M, Johnson TP, Wislar JS, Hubbell A, Spiehler V (2004). The utility of drug testing in epidemiological research: results from a general population survey. Addiction 99, 197-208.
14. Ferdinand RF, Sondeijker F, van der Ende J, Selten JP, Huizink A, Verhulst FC (2005). Cannabis use predicts future psychotic symptoms, and vice versa. Addiction 100, 612-618.
15. Fergusson DM, Poulton R, Smith PF, Boden JM (2006). Cannabis and psychosis. British Medical Journal 332, 172-175.
16. Hall W, Degenhardt L, Teesson M (2004). Cannabis use and psychotic disorders: an update. Drug and Alcohol Review 23, 433-443.
17. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, van Os J (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330, 11-14.
18. Henquet C, Rosa A, Krabbendam L, Papiol S, Fananas L, Drukker M, Ramaekers JG, van Os J (2006). An experimental study of catechol-O- methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 31, 2748-2757.
19. Honig A, Romme MA, Ensink BJ, Escher SD, Pennings MH, deVries MW (1998). Auditory hallucinations: a comparison between patients and nonpatients. Journal of Nervous and Mental Disease 186, 646-651.
20. Koethe D, Gerth CW, Neatby MA, Haensel A, Thies M, Schneider U, Emrich HM, Klosterkotter J, Schultze-Lutter F, Leweke FM (2006). Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness. Schizophrenia Research 883, 142-150.
21. Kwapil TR (1996). A longitudinal study of drug and alcohol use by psychosis-prone and impulsive non-conforming individuals. Journal of Abnormal Psychology 105, 114-123.
22. Linszen DH, Dingemans PM, Lenior ME (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51, 273-279.
23. Moss R, Bardang C, Kindl K, Dahme B (2001). Relationship between cannabis use, schizotypal traits and cognitive function in healthy subjects. Psychopathology 34, 209-214.
24. Raine A (1991). The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 17, 555-564.
25. Schiffman J, Nakamura B, Earleywine M, LaBrie J (2005). Symptoms of schizotypy precede cannabis use. Psychiatry Research 134, 37-42.
26. Skosnik PD, Spatz-Glenn L, Park S (2001). Cannabis use is associated with schizotypy and attentional disinhibition. Schizophrenia Research 48, 83-92.
27. van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H (2002). Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 156, 319-327.
28. Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen JD (2003). Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine 33, 23-32.
29. Verdoux H, Tournier M, Cougnard A (2005). Impact of substance use on the onset and course of early psychosis. Schizophrenia Research 79, 69-75.
30. Williams JH, Wellman JN, Rawlins JNP (1996). Cannabis use correlates with schizotypy in healthy people. Addiction 91, 869-877.